stempro ® msc sfm medium (Thermo Fisher)
Thermo Fisher is a verified supplier 
Thermo Fisher manufactures this product 
90
Structured Review
Thermo Fisher
stempro ® msc sfm medium
Stempro ® Msc Sfm Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stempro%C2%AE-34+sfm+medium/stempro+msc+medium/pmc11979104-71-19-24
Average 90 stars, based on 1 article reviews
Stempro ® Msc Sfm Medium, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stempro%C2%AE-34+sfm+medium/stempro+msc+medium/pmc11979104-71-19-24
Average 90 stars, based on 1 article reviews
stempro ® msc sfm medium - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Isolation:Article Title: Generation of human induced pluripotent stem cell line from peripheral blood of patient with lymphedema-distichiasis syndrome Article Snippet: 100 000 cells were transduced with Sendai vectors ( Article Title: Generation of an integration-free induced pluripotent stem cell (iPSC) line (SDHI001-A) from a 65-year old adult mitral valve prolapse (MVP) patient. Article Snippet: These cells were then cultured on plates coated with recombinant human vitronectin (rhVTNN, Gibco) in Article Title: Generation of two induced pluripotent stem cell lines from Loeys-Dietz syndrome patients carrying heterologous mutation of TGFBR1 Article Snippet: After isolation, the PBMCs were cultured in Article Title: An iPSC model of fragile X syndrome reflects clinical phenotypes and reveals m 6 A-mediated epi-transcriptomic dysregulation underlying synaptic dysfunction Article Snippet: A total of 500,000 PBMCs were seeded in 24-well plates and cultured in PBMC medium [StemPro ® -34 SFM medium (ThermoFisher) supplemented with SCF (100ng/mL; Peprotech), FLT-3 (100ng/mL; Peprotech), IL-3 (20ng/mL; Peprotech), and IL-6 (20ng/mL; Peprotech)] for four days. Article Title: Generation of induced pluripotent stem cell line from a patient with long COVID Article Snippet: Culturing media consisted of StemPro®-34 SFM medium supplemented with specific growth factors and cytokines: 100 ng/mL Article Title: Generation of two induced pluripotent stem cell lines from breast cancer patients carrying BRCA1 mutations Article Snippet: Reprogramming PBMCs were isolated from whole blood using Percoll® density gradient medium (GE Healthcare #17089109), washed with PBS, and cultured in Article Title: Generation of a human induced pluripotent stem cell lines (UKJi003-A) from a patient with Fabry disease and healthy donor (UKJi004-A) Article Snippet: The PBMCs were then incubated for three days in StemPro®-34 92 Article Title: Generation of human induced pluripotent stem cell lines UKJi001-A and UKJi006-A from patients with heterozygous mutation in the PKP2 gene. Article Snippet: One of the main signs we do not know enough about arrhythmogenic right ventricular dysplasia 9/cardiomyopathy (ARVCD9, OMIM #609040, autosomal dominant) is the lack of early markers and therapeutic alternatives.. To better study disease pathways in vitro, we generated human induced pluripotent stem cell (hiPSC) lines from the father (UKJi006-A) and son (UKJi001-A), who both shared the same heterozygous mutation in the PKP2 gene (OMIM *602861).. While the father had a clinical diagnosis of ARVC, the son lacked the ARVC phenotype. Cell Culture:Article Title: Generation of human induced pluripotent stem cell line from peripheral blood of patient with lymphedema-distichiasis syndrome Article Snippet: 100 000 cells were transduced with Sendai vectors ( Article Title: Generation of an integration-free induced pluripotent stem cell (iPSC) line (SDHI001-A) from a 65-year old adult mitral valve prolapse (MVP) patient. Article Snippet: These cells were then cultured on plates coated with recombinant human vitronectin (rhVTNN, Gibco) in Article Title: Generation of two induced pluripotent stem cell lines from Loeys-Dietz syndrome patients carrying heterologous mutation of TGFBR1 Article Snippet: After isolation, the PBMCs were cultured in Article Title: An iPSC model of fragile X syndrome reflects clinical phenotypes and reveals m 6 A-mediated epi-transcriptomic dysregulation underlying synaptic dysfunction Article Snippet: A total of 500,000 PBMCs were seeded in 24-well plates and cultured in PBMC medium [StemPro ® -34 SFM medium (ThermoFisher) supplemented with SCF (100ng/mL; Peprotech), FLT-3 (100ng/mL; Peprotech), IL-3 (20ng/mL; Peprotech), and IL-6 (20ng/mL; Peprotech)] for four days. Article Title: Generation of induced pluripotent stem cell line from a patient with long COVID Article Snippet: Culturing media consisted of StemPro®-34 SFM medium supplemented with specific growth factors and cytokines: 100 ng/mL Article Title: Generation of two induced pluripotent stem cell lines from breast cancer patients carrying BRCA1 mutations Article Snippet: Reprogramming PBMCs were isolated from whole blood using Percoll® density gradient medium (GE Healthcare #17089109), washed with PBS, and cultured in Article Title: Generation of a human induced pluripotent stem cell lines (UKJi003-A) from a patient with Fabry disease and healthy donor (UKJi004-A) Article Snippet: The PBMCs were then incubated for three days in StemPro®-34 92 Article Title: Generation of human induced pluripotent stem cell lines UKJi001-A and UKJi006-A from patients with heterozygous mutation in the PKP2 gene. Article Snippet: One of the main signs we do not know enough about arrhythmogenic right ventricular dysplasia 9/cardiomyopathy (ARVCD9, OMIM #609040, autosomal dominant) is the lack of early markers and therapeutic alternatives.. To better study disease pathways in vitro, we generated human induced pluripotent stem cell (hiPSC) lines from the father (UKJi006-A) and son (UKJi001-A), who both shared the same heterozygous mutation in the PKP2 gene (OMIM *602861).. While the father had a clinical diagnosis of ARVC, the son lacked the ARVC phenotype. Recombinant:Article Title: Generation of human induced pluripotent stem cell line from peripheral blood of patient with lymphedema-distichiasis syndrome Article Snippet: 100 000 cells were transduced with Sendai vectors ( Article Title: Generation of an integration-free induced pluripotent stem cell (iPSC) line (SDHI001-A) from a 65-year old adult mitral valve prolapse (MVP) patient. Article Snippet: These cells were then cultured on plates coated with recombinant human vitronectin (rhVTNN, Gibco) in Article Title: Generation of two induced pluripotent stem cell lines from Loeys-Dietz syndrome patients carrying heterologous mutation of TGFBR1 Article Snippet: After isolation, the PBMCs were cultured in Article Title: An iPSC model of fragile X syndrome reflects clinical phenotypes and reveals m 6 A-mediated epi-transcriptomic dysregulation underlying synaptic dysfunction Article Snippet: A total of 500,000 PBMCs were seeded in 24-well plates and cultured in PBMC medium [StemPro ® -34 SFM medium (ThermoFisher) supplemented with SCF (100ng/mL; Peprotech), FLT-3 (100ng/mL; Peprotech), IL-3 (20ng/mL; Peprotech), and IL-6 (20ng/mL; Peprotech)] for four days. Article Title: Generation of induced pluripotent stem cell line from a patient with long COVID Article Snippet: Culturing media consisted of StemPro®-34 SFM medium supplemented with specific growth factors and cytokines: 100 ng/mL Article Title: Generation of two induced pluripotent stem cell lines from breast cancer patients carrying BRCA1 mutations Article Snippet: Reprogramming PBMCs were isolated from whole blood using Percoll® density gradient medium (GE Healthcare #17089109), washed with PBS, and cultured in Article Title: Generation of a human induced pluripotent stem cell lines (UKJi003-A) from a patient with Fabry disease and healthy donor (UKJi004-A) Article Snippet: The PBMCs were then incubated for three days in StemPro®-34 92 Article Title: Generation of human induced pluripotent stem cell lines UKJi001-A and UKJi006-A from patients with heterozygous mutation in the PKP2 gene. Article Snippet: One of the main signs we do not know enough about arrhythmogenic right ventricular dysplasia 9/cardiomyopathy (ARVCD9, OMIM #609040, autosomal dominant) is the lack of early markers and therapeutic alternatives.. To better study disease pathways in vitro, we generated human induced pluripotent stem cell (hiPSC) lines from the father (UKJi006-A) and son (UKJi001-A), who both shared the same heterozygous mutation in the PKP2 gene (OMIM *602861).. While the father had a clinical diagnosis of ARVC, the son lacked the ARVC phenotype. |